BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32840620)

  • 1. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
    Peultier AC; Pandya A; Sharma R; Severens JL; Redekop WK
    JAMA Netw Open; 2020 Aug; 3(8):e2012476. PubMed ID: 32840620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke.
    Pizzo E; Dumba M; Lobotesis K
    Int J Stroke; 2020 Jan; 15(1):75-84. PubMed ID: 30758277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom.
    Peultier AC; Redekop WK; Allen M; Peters J; Eker OF; Severens JL
    Stroke; 2019 Nov; 50(11):3220-3227. PubMed ID: 31637975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.
    Ni W; Kunz WG; Goyal M; Ng YL; Tan K; De Silva DA
    BMJ Open; 2020 Sep; 10(9):e036517. PubMed ID: 32948553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective.
    Arora N; Makino K; Tilden D; Lobotesis K; Mitchell P; Gillespie J
    J Med Econ; 2018 Aug; 21(8):799-809. PubMed ID: 29741126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombectomy is a cost-saving procedure up to 24 h after onset.
    Nivelle E; Dewilde S; Peeters A; Vanhooren G; Thijs V
    Acta Neurol Belg; 2022 Feb; 122(1):163-171. PubMed ID: 34586595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEFUSE 3 Non-DAWN Patients.
    Leslie-Mazwi TM; Hamilton S; Mlynash M; Patel AB; Schwamm LH; Lansberg MG; Marks M; Hirsch JA; Albers GW
    Stroke; 2019 Mar; 50(3):618-625. PubMed ID: 30727856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular thrombectomy in patients with large core ischemic stroke: a cost-effectiveness analysis from the SELECT study.
    Sarraj A; Pizzo E; Lobotesis K; Grotta JC; Hassan AE; Abraham MG; Blackburn S; Day AL; Dannenbaum MJ; Hicks W; Vora NA; Budzik RF; Sharrief AZ; Martin-Schild S; Sitton CW; Pujara DK; Lansberg MG; Gupta R; Albers GW; Kunz WG;
    J Neurointerv Surg; 2021 Oct; 13(10):875-882. PubMed ID: 33188155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated CT Perfusion Imaging to Aid in the Selection of Patients With Acute Ischemic Stroke for Mechanical Thrombectomy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(13):1-87. PubMed ID: 33240454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core.
    Sanmartin MX; Katz JM; Wang J; Malhotra A; Sangha K; Bastani M; Martinez G; Sanelli PC
    J Neurointerv Surg; 2023 Nov; 15(e2):e166-e171. PubMed ID: 36175016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of endovascular treatment after 6-24 h in ischaemic stroke patients with collateral flow on CT-angiography: A model-based economic evaluation of the MR CLEAN-LATE trial.
    Pinckaers FM; Evers SM; Olthuis SG; Boogaarts HD; Postma AA; van Oostenbrugge RJ; van Zwam WH; Grutters JP
    Eur Stroke J; 2024 Jun; 9(2):348-355. PubMed ID: 38153049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.
    Sarraj A; Mlynash M; Savitz SI; Heit JJ; Lansberg MG; Marks MP; Albers GW
    JAMA Neurol; 2019 Jun; 76(6):682-689. PubMed ID: 30734042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study.
    Dittrich TD; Sporns PB; Kriemler LF; Rudin S; Nguyen A; Zietz A; Polymeris AA; Tränka C; Thilemann S; Wagner B; Altersberger VL; Piot I; Barinka F; Müller S; Hänsel M; Gensicke H; Engelter ST; Lyrer PA; Sutter R; Nickel CH; Katan M; Peters N; Kulcsár Z; Karwacki GM; Pileggi M; Cereda C; Wegener S; Bonati LH; Fischer U; Psychogios M; De Marchis GM
    Stroke; 2023 Mar; 54(3):722-730. PubMed ID: 36718751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke.
    Sanmartin MX; Katz JM; Eusemann C; Boltyenkov AT; Sangha K; Bastani M; Turner R; Siddiqui AH; Mendes Pereira V; Hui FK; Mocco J; Sanelli PC
    J Neurosurg; 2023 Sep; 139(3):721-731. PubMed ID: 36670531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy.
    Ruggeri M; Basile M; Zini A; Mangiafico S; Agostoni EC; Lobotesis K; Saver J; Coretti S; Drago C; Cicchetti A
    J Med Econ; 2018 Sep; 21(9):902-911. PubMed ID: 29882711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke: Role of Predicted Recanalization Rates.
    Schlemm L; Endres M; Nolte CH
    Circ Cardiovasc Qual Outcomes; 2021 Apr; 14(4):e007444. PubMed ID: 33813852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Mechanical Thrombectomy for Treatment of Nonminor Ischemic Stroke Across Europe.
    Candio P; Violato M; Leal J; Luengo-Fernandez R
    Stroke; 2021 Jan; 52(2):664-673. PubMed ID: 33423511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of the first pass effect in mechanical thrombectomy for acute ischaemic stroke treatment in Spain: a cost-effectiveness analysis from the national health system perspective.
    González Diaz E; Rodríguez-Paz C; Fernandez-Prieto A; Martínez-Galdámez M; Martínez-Moreno R; Ortega Quintanilla J; Tomasello A; Zamarro J; Liebeskind D; Zaidat OO; Mueller-Kronast NH
    BMJ Open; 2022 Sep; 12(9):e054816. PubMed ID: 36258310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.